Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: RMD

ResMed Inc.

Healthcare | Medical - Devices
$228.35 -0.84 (-0.37%) as of 2026-09-06 03:54 UTC
Market Cap$33.1B
Volume837.6K
EPS (TTM)$10.43

ResMed Inc. (NYSE: RMD) is a $33.1B medical - devices company trading at $228.35 (−0.4% today) — 21.9× trailing earnings, yielding 1.05%. Figures from SEC EDGAR and market feeds; updated 2026-09-06 03:54 UTC.

52-Week Range
Low $180.26High $242.40

What ResMed Inc. does

ResMed is a global digital health company that designs cloud-connected medical devices and software to treat chronic respiratory conditions and support residential care. The company pioneered CPAP treatment for obstructive sleep apnea and has since expanded into a range of respiratory devices, diagnostic products, masks, accessories, and cloud-based health applications that help clinicians manage patients and encourage treatment adherence.

Summarized from ResMed Inc.’s SEC filings · Read the filing ↗

Key facts

Quote
Price$228.35
Change (1D)-0.84 (-0.37%)
Market cap$33.1B
Volume837.6K shares
52-week range$180.26 – $242.40
Valuation
P/E (TTM)21.89×
EV/EBITDA15.50×
EPS (TTM)$10.43
Dividend yield1.05%
Price/book5.03×
Return on equity23.13%
Debt/equity0.10
Returns
52-week return+26.7%

Revenue, margins & earnings

FY2022 Net income: $779MFY2022 Taxes & interest: $221MFY2022 Operating expenses: $1.02BFY2022 Cost of revenue: $1.55B$3.58BFY2022FY2023 Net income: $898MFY2023 Taxes & interest: $234MFY2023 Operating expenses: $1.22BFY2023 Cost of revenue: $1.87B$4.22BFY2023FY2024 Net income: $1.02BFY2024 Taxes & interest: $299MFY2024 Operating expenses: $1.34BFY2024 Cost of revenue: $2.03B$4.69BFY2024FY2025 Net income: $1.40BFY2025 Taxes & interest: $285MFY2025 Operating expenses: $1.37BFY2025 Cost of revenue: $2.09B$5.15BFY2025FY2026 Net income: $1.52BFY2026 Taxes & interest: $363MFY2026 Operating expenses: $1.57BFY2026 Cost of revenue: $2.20B$5.65BFY2026
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-04
  • 2026-09-04FARRELL PETER CSELL-970$227.7K
  • 2026-08-11Farrell Michael J.Chairman and CEOSELL-4,991$1.03M
  • 2026-08-11Farrell Michael J.Chairman and CEOM4,991$730.4K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does ResMed Inc. do?

ResMed is a global digital health company that designs cloud-connected medical devices and software to treat chronic respiratory conditions and support residential care.

What is RMD's valuation?

RMD trades at $228.35, 21.89× trailing earnings, 15.50× EV/EBITDA, as of 2026-09-06. It carries a 1.05% dividend yield.

When did RMD last file with the SEC?

ResMed Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-07. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-09-06 03:54 UTC. This page is also available as JSON at /api/data?ticker=RMD and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for RMD and 5,000+ tickers.

Create a free account — keep RMD
For your agent
GET /api/data?ticker=RMD

This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt